A detailed history of Clearstead Trust, LLC transactions in Organon & Co. stock. As of the latest transaction made, Clearstead Trust, LLC holds 15 shares of OGN stock, worth $236. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15
Previous 15 -0.0%
Holding current value
$236
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$13.78 - $18.8 $234 - $319
-17 Reduced 53.13%
15 $0
Q4 2023

Feb 06, 2024

SELL
$10.95 - $17.32 $1,127 - $1,783
-103 Reduced 76.3%
32 $0
Q2 2023

Aug 08, 2023

SELL
$19.27 - $24.63 $269 - $344
-14 Reduced 9.4%
135 $2,000
Q1 2023

May 10, 2023

SELL
$21.42 - $32.08 $5,847 - $8,757
-273 Reduced 64.69%
149 $3,000
Q4 2022

Jan 31, 2023

SELL
$23.31 - $28.61 $6,247 - $7,667
-268 Reduced 38.84%
422 $12,000
Q3 2022

Nov 10, 2022

BUY
$23.4 - $34.25 $16,145 - $23,632
690 New
690 $16,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Clearstead Trust, LLC Portfolio

Follow Clearstead Trust, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Trust, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Trust, LLC with notifications on news.